🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this research study, our main goal for the ipilimumab portion of the stu...
Status
Active Not Recruiting
Location
Brigham and Women's Hospital
Start Date
2019-07-10
Trial ID
NCT03912064
Treatments Being Tested
In the laboratory, we will put a special gene into cancer cells that have b...
Status
Withdrawn
Location
Multiple Locations
Start Date
2005-09
Trial ID
NCT00224354
Treatments Being Tested
RATIONALE: Vaccines made from a person's white blood cells mixed with tumor...
Status
Completed
Location
Dermatologische Klinik mit Poliklinik - Universitaetsklinikum Erlangen
Start Date
2002-10
Trial ID
NCT00056134
Treatments Being Tested
Background: * Pediatric solid tumors (Ewing's sarcoma, rhabdomyosarcoma, a...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2007-06-02
Trial ID
NCT00923351
Exploring the efficacy of PD-1 inhibitor combination therapy strategies for...
Status
Not Yet Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2024-09-30
Trial ID
NCT06620822
Treatments Being Tested
The purpose of this study is to test whether regulatory T-cell reduction is...
Status
Completed
Location
University of Chicago
Start Date
2011-07-12
Trial ID
NCT01526096
Epithelial ovarian cancer (OC) is the most lethal gynecologic cancer: nearl...
Status
Active Not Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2022-09-30
Trial ID
NCT05200559
Treatments Being Tested
The purpose of this research study is to evaluate the safety and efficacy o...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2007-12
Trial ID
NCT00675831
Treatments Being Tested
The objective of this study is to evaluate the safety and immunologic effec...
Status
Terminated
Location
Providence Portland Medical Center
Start Date
2009-07
Trial ID
NCT00961376
Treatments Being Tested
This study looks at giving specific types of immune cells, called regulator...
Status
Completed
Location
Stanford University School of Medicine Palo Alto, California, United States
Start Date
2012-02-09
Trial ID
NCT01660607